Details

For information on this past event please contact Meetings Management

URGENT NOTICE: Please note that IVW 2006 is NOW SOLD OUT

We cannot under any circumstances accommodate any more registrations for IVW 2006 at the Palais Ferstl. However there is now the possibility to book onto the real-time broadcast event close to the main conference venue. This will provide the opportunity to listen and view all of the IVW 2006 oral sessions. Coffees, teas and lunches will be provided daily and the full set of conference materials are included in the registration fee. There will however be no access allowed to the main conference event due to the restriction on numbers at the Palais Ferstl.

The registration fee to attend the real-time broadcast IVW 2006 event is £845 UK pounds sterling. Again places are limited and we expect this event to be sold out so do not delay and please make your booking immediately.

At this late stage we will only accept payment by visa/mastercard credit cards. If you wish to book onto the real-time broadcast of the IVW 2006 conference please click here.

It is important that you enter the name of your organization/company in the address details that you enter on the secure order form. Without this information your registration cannot be processed.

Please do not make any plans to travel to Vienna if you have not yet registered and have not received confirmation of your place being booked on either the IVW 2006 conference proper of the IVW 2006 real-time broadcast event.

Second Circular and Provisional Conference Program

The Second International Conference on

Influenza Vaccines for the World
18-20 October 2006, Palais Ferstl, Vienna, Austria

‘The control and management of influenza are currently based on the surveillance, prevention and treatment of the disease. Almost all European countries have influenza immunization policies for populations considered as being at-risk, but there are large disagreements about the meaning of ‘risk’ and the levels of vaccine use vary greatly country by country. In the near future, new vaccines and specific anti-viral drugs will need to adapt and to extend current recommendations…’
– Rene Snacken (Scientific Institute of Public Health-Louis Pasteur, Belgium)

‘The natural history of influenza suggests it is only a matter of time before another influenza pandemic occurs… Vaccinating predefined segments of the population will be one of the major strategies for reducing the impact of pandemic influenza, and the net return, in dollars, from vaccination is an important economic measure of the costs and benefits associated with vaccination.’
– Martin Meltzer (CDC, AtIanta, USA)

‘The pandemic clock is ticking; we just don’t know what time it is.’
– Edgar Marcuse (University of Washington School of Medicine, USA)

IVW 2006 – The World Influenza Vaccination Conference

IVW 2006 is the follow-up meeting to the successful IVW 2004 meeting held in Lisbon, Portugal in May 2004. A clear indicator from IVW 2004 was a desire for another IVW conference to be scheduled and IVW 2006 will now take place in Vienna. There is a clear demand for an international conference that aims to focus on ‘Influenza vaccination issues’. IVW 2006 will build on the success of the Lisbon conference and will aim to complement the ESWI conference series and also the ‘Options for Control and Prevention of Influenza’ series of events.

IVW 2006 will be an international forum for world renowned experts in the field of influenza vaccines and related issues to report the latest data and trends associated with current and new influenza vaccines and their availability/delivery worldwide.

Scientific Advisory Panel

Nancy Cox (CDC, Atlanta, USA)
Klaus Stöhr (WHO, Geneva, Switzerland)
Valentine Delore (Sanofi-Pasteur, Lyon, France)
Rob Lambkin (Retroscreen Virology Ltd, London, UK)
Reinhard Glück (Berna Biotech, Switzerland)
Martin Meltzer (CDC, Atlanta, USA)
John Wood (NIBSC, UK)
John S Tam (Chinese University of Hong Kong, Hong Kong)
Douglas Fleming (RCGP, Birmingham, UK)
Albert Osterhaus (Erasmus University, Rotterdam, The Netherlands)
Jim Robertson (NIBSC, Potters Bar, UK)
Bram Palache (IVS International Task Force Representative)
John S. Oxford (Queen Mary’s School of Medicine & Dentistry, London, UK)
Ada Minutello (Novartis Vaccines, Morburg, Germany)

Conference Scope

IVW 2006 will address the following important topics:

Surveillance Issues / Burden of Disease
Immunological Issues
Social / Political / Financial Issues Surrounding Influenza Vaccination
Production / Formulation Issues / Manufacturing Issues
Vaccine Usage / Targeting Strategies
Influenza Vaccines / Adjuvants – Improvement Issues
Pandemic Preparedness Issues / Licensing Issues
Novel Developments

The scientific programme will include keynote lectures, contributed papers, workshops, panel discussions and poster presentations emphasising all aspects of ‘Influenza Vaccines’ and their usage and effectiveness.

Sponsored by